Primary induction of human CD8+cytotoxic T lymphocytes and interferon-γ-producing T cells after smallpox vaccination

Journal of Infectious Diseases

Volumn 185, Issue 11, 2002, Pages 1657-1659

  Ennis, Francis A ^a   Cruz, John ^a   Demkowicz, Walter E ^a,c,d   Rothman, Alan L ^a   McClain, David J ^b,c,d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c GENZYME CORPORATION   (United States)

^d 445 Biltmore Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; SMALLPOX VACCINE;

ARTICLE; CELL KINETICS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INFECTION RISK; MEMORY CELL; PRIORITY JOURNAL; SCAR FORMATION; SMALLPOX; T LYMPHOCYTE ACTIVATION; TREATMENT INDICATION; TREATMENT PLANNING; VACCINATION;

ADULT; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; SMALLPOX VACCINE; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINIA VIRUS;

EID: 0036606181     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340517     Document Type: Article

References (15)

1. An inquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western countries of England, particularly Gloucestershire, and known by the name of the cow pox
2. Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration: Standard percutaneous revaccination of children who received primary percutaneous vaccination
3. Clinical and immunological study of percutaneous revaccination in children who originally received smallpox vaccine subcutaneously
4. Studies in mousepox (infectious ectromelia of mice). IV. Quantitative investigations on the spread of virus through the host in actively and passively immunized animals
5. Class I major histocompatibility complex-restricted cytotoxic T cell responses to vaccinia virus in humans
6. Progressive vaccinia with normal antibodies: A case possibly due to deficient cellular immunity
7. Progressive vaccinia in immunologically deficient individuals
8. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease
9. Immunologic responses to vaccinia vaccines administered by different parenteral routes
10. +cytotoxic T lymphocytes in humans
11. Human cytotoxic T-cell memory: Long-lived responses to vaccinia virus
12. Human cytotoxic T-lymphocyte repertoire to influenza A viruses
13. Safety and immunological response to a recombinant vaccinia virus expressing the HIV envelope glycoprotein